Medical and Biological Laboratories Co., Ltd. (President: Kimimasa Yamada), a JSR Life Sciences company, announced today that it has received its “EU Quality Management System Certificate under the new In Vitro Diagnostic Medical Device Regulation (IVDR). The certification ensures that the CE marked diagnostic products supplied by MBL adhere to standards of quality and safety that ensure the highest level of patients’ health protection.
IVDR certification is granted by the European Commission to products and organizations that have been approved reviewed and found to be in compliance with the In Vitro Diagnostics Regulation (IVDR), the latest regulation for in vitro diagnostic medical devices in the EU for product safety and efficacy. With IVDR certification MBL will be able to display the CE mark on product packaging and continue to expand the products it supplies within the EU.
The MESACUP tests measureskin-specific autoantibodies in serum by *ELISA. By identifying and measuring autoantibodies, it is used as an aid in the diagnosis of autoimmune bullous disease(pemphigus, pemphigoid), a skin-specific autoimmune disease, and for the monitoring of the response to therapy for treatment.
The HEXAMATE line of products are reagents for measuring coagulation factor XIII in plasma by latex immunoturbidimetry and aid in the diagnosis of factor XIII deficiency.
Contact details
-
- Missy Bindseil
-
JSR Life Sciences Company Inquiries
Director, Marketing & Communications - mbindseil@jsr-nahq.com
Related topics
Related news
New Antibody Development for Use in Drug Delivery to Motor Nerves
MBL raised and delivered monoclonal antibodies for Jiksak Bioengineering, a startup company with proprietary technologies developed for new therapeutic innovation in motor neuron degenerative disea...
MBL Obtains Regulatory Approval for SARS-CoV-2 and Influenza Virus Antigen Test OTC Kit
This product detects the SARS-CoV-2 and Influenza virus antigen in nasal swab fluid by the immunochromatography method. MBL can sell this product at pharmacies, drugstores and pharmacy online sites.
MBL Launches an OTC Kit for SARS-CoV-2 Antigen Test
Medical & Biological Laboratories Co., Ltd. successfully acquired regulatory approval on November 11, 2022 for its SARS-CoV-2 antigen test OTC kit “GLINE-2019-nCoV Agキット(一般用).”
Crown Bioscience & MBL Launch Joint Venture to Serve Japanese Biopharmaceutical Community
Crown Bioscience & MBL, a joint venture between two JSR Life Sciences companies formed earlier this year, announce today the launch of their full-service drug discovery and development capabilities...
MBL Launches a Kit for Simultaneous Detection of SARS-CoV-2 and Influenza Virus Antigens
This kit detects the SARS-CoV-2 antigen, influenza A virus antigen, and influenza B virus antigen in nasopharyngeal or nasal swab fluid using an immunochromatographic method.